Who should have breast magnetic resonance imaging evaluation?
- PMID: 18258977
- DOI: 10.1200/JCO.2007.14.3594
Who should have breast magnetic resonance imaging evaluation?
Abstract
During the last two decades, tremendous advances have been made in the performance and interpretation of breast magnetic resonance imaging (MRI) examinations. Technical requirements for optimal breast imaging including the requirement for a breast MRI biopsy system are now being defined as part of a voluntary American College of Radiology (ACR) breast MRI accreditation program. The ACR BI-RADS (Breast Imaging Reporting and Data System) lexicon for breast MRI has brought uniformity to the interpretation of breast MRI examinations. With these advances in imaging technique, interpretation guidelines, and increasing availability of MR-compatible breast biopsy systems, MRI of the breast is rapidly gaining popularity in clinical practice in both the diagnostic setting and, more recently, in the screening setting. The clinical indications for breast MRI, however, remain to be defined. There are clinical indications that have emerged where MRI, as an adjunct to mammography, seems to be the imaging study of choice. There are other indications, specifically breast cancer staging, in which MRI is being utilized with increasing frequency, but in which controversy persists.
Similar articles
-
The challenge of imaging dense breast parenchyma: is magnetic resonance mammography the technique of choice? A comparative study with x-ray mammography and whole-breast ultrasound.Invest Radiol. 2009 Jul;44(7):412-21. doi: 10.1097/RLI.0b013e3181a53654. Invest Radiol. 2009. PMID: 19448554
-
Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer.J Am Coll Radiol. 2010 Jan;7(1):18-27. doi: 10.1016/j.jacr.2009.09.022. J Am Coll Radiol. 2010. PMID: 20129267
-
[The "EVA" Trial: Evaluation of the Efficacy of Diagnostic Methods (Mammography, Ultrasound, MRI) in the secondary and tertiary prevention of familial breast cancer. Preliminary results after the first half of the study period].Rofo. 2005 Jun;177(6):818-27. doi: 10.1055/s-2005-858203. Rofo. 2005. PMID: 15902631 Clinical Trial. German.
-
[Revised practice guideline 'Screening and diagnosis of breast cancer'].Ned Tijdschr Geneeskd. 2008 Oct 25;152(43):2336-9. Ned Tijdschr Geneeskd. 2008. PMID: 19024064 Review. Dutch.
-
Breast MR imaging in the diagnostic setting.Magn Reson Imaging Clin N Am. 2006 Aug;14(3):329-37, vi. doi: 10.1016/j.mric.2006.07.004. Magn Reson Imaging Clin N Am. 2006. PMID: 17098174 Review.
Cited by
-
Breast magnetic resonance imaging as a problem-solving modality in mammographic BI-RADS 3 lesions.Cancer Imaging. 2010 Oct 4;10 Spec no A(1A):S54-8. doi: 10.1102/1470-7330.2010.9020. Cancer Imaging. 2010. PMID: 20880790 Free PMC article. Review.
-
Classification of MR-Detected Additional Lesions in Patients With Breast Cancer Using a Combination of Radiomics Analysis and Machine Learning.Front Oncol. 2021 Dec 2;11:744460. doi: 10.3389/fonc.2021.744460. eCollection 2021. Front Oncol. 2021. PMID: 34926256 Free PMC article.
-
The Role of MR Mammography in Differentiating Benign from Malignant in Suspicious Breast Masses.J Clin Diagn Res. 2016 Sep;10(9):TC05-TC08. doi: 10.7860/JCDR/2016/21820.8456. Epub 2016 Sep 1. J Clin Diagn Res. 2016. PMID: 27790545 Free PMC article.
-
Clinical findings and outcomes of MRI staging of breast cancer in a diverse population.Breast Cancer Res Treat. 2019 Apr;174(2):315-324. doi: 10.1007/s10549-018-05084-w. Epub 2018 Dec 12. Breast Cancer Res Treat. 2019. PMID: 30542816 Free PMC article.
-
Use of Breast Imaging After Treatment for Locoregional Breast Cancer (AFT-01).Ann Surg Oncol. 2018 Jun;25(6):1502-1511. doi: 10.1245/s10434-018-6359-z. Epub 2018 Feb 15. Ann Surg Oncol. 2018. PMID: 29450753 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical